Equine & Livestock

2022 AAEP Buyer's Guide

Issue link: https://www.e-digitaleditions.com/i/1482817

Contents of this Issue

Navigation

Page 22 of 51

J U S T W H A T M A T T E R S With some equine vaccines, there's loose interpretation about efficacy. Some say blood titers are the predictor of protection. But they are only part of the immune response. Vetera® Gold XP is proven through actual disease challenge. 1,2,3 Millions of doses have been used by veterinarians. That's just what matters. VETERA® is a registered trademark of Boehringer Ingelheim Vetmedica GmBH, used under license. ©2022 Boehringer Ingelheim Animal Health USA Inc., Duluth, GA. All rights reserved. US-EQU-0107-2020-V2 1 West Nile Virus Challenge Vaccine Efficacy, BI study number: V9 2009 WNV 12mo DOI 2 Equine Influenza Challenge, BI study number: 01 V9 6mo DOI OH/03. 3 Lack of Interference - Influenza Challenge, BI study number: 2012-001 Inf. Data on file at Boehringer Ingelheim. NOT JUST TEST TUBES CHALLENGED IN THE REAL WORLD

Articles in this issue

Archives of this issue

view archives of Equine & Livestock - 2022 AAEP Buyer's Guide